Introduction
Regulation of cellular metabolism and growth by insulin is a result of a series of events initiated by the interaction of the hormone with specific cell surface receptors. In the past, insulin receptors on a large number of cell types from different vertebrates have been characterized in detail by their functional properties: recognition of the hormone by a noncovalent binding reaction, transmembrane signalling, and activation ofcell metabolism. It also became clear that receptors mediate proteolytic degradation of insulin, probably via endocytosis of the receptor-bound hormone. These results were primarily based on studies of the interaction of radioiodinated insulin with isolated cells or plasma membranes (for reviews see Kahn et al., 1981; Gammeltoft, 1984) . The insulin receptor structure has been elucidated through affinity labelling of receptors by chemical cross-linking with 125I-insulin, biosynthetic or cell-surface labelling of receptor subunits (for reviews see Jacobs&Cuatrecasas, 1981 ; Czech, 1984; VanObberghen, 1984) . Recently, the complete amino-acid sequence of the human insulin receptor precursor was unravelled by application of recombinant DNA technology (Ullrich et al., 1985; Ebina et al., 1985) . In spite ofthis progress the molecular mechanism of insulin action is still poorly comprehended regarding the events following the receptor binding and leading to the ultimate cellular responses. Possible mechanisms of intracellular signal transmission include changes in intracellular Ca2+ concentration, protein phosphorylation, release ofpeptide mediators, interaction with guanine nucleotide regulatory proteins and internalization of receptor-hormone complexes, but attempts to identify a second messenger in insulin action has so far been inconclusive (for reviews see Denton et al., 1981; Houslay, 1981; Houslay & Heyworth, 1983; Czech, 1984; Bergeron et al., 1985; Cheng & Lamer, 1985) .
Recently, a promising discovery was made by the demonstration that the insulin receptor is an insulinsensitive protein kinase (Kasuga et al., 1982a; Van Obberghen & Kowalski, 1982; Avruch et al., 1982; Petruzzelli et al., 1982) . This novel observation is of interest for our understanding of insulin-regulated processes, since it is now recognized that covalent phosphorylation-dephosphorylation of proteins is a mechanism whereby many cellular functions are regulated by hormones and neurotransmitters (Denton et al., 1981; Cohen, 1982; Houslay, 1981) . Furthermore, protein kinases are also constituents of receptors for several polypeptide growth factors, including epidermal growth factor (EGF) (Cohen et al., 1980) , platelet-derived growth factor (PDGF) (Ek et al., 1982) , transforming growth factor (TGF-a) (Reynolds et al., 1981) , and insulin-like growth factor I (IGF-I) (Jacobs et al., 1983 , implying that receptor kinase activity may represent a general mechanism in transmembrane signalling of hormones and growth factors. The purpose of the present Review is to describe the current status of functional and structural properties of insulin receptors in vertebrates. We will briefly summarize the functional properties of insulin receptors in metabolic regulation and insulin degradation. We emphasize the new advances in our knowledge about the insulin receptor protein structure and the recent discovery of the protein kinase activity of the receptor. Finally, the structural and functional heterogeneity of insulin receptors will be discussed.
Functional properties of insulin receptor
Earlier suggestions that insulin induces its biological actions at the plasma membrane level via combination with receptors of protein nature have been confirmed in a large number of studies of 1251-insulin binding during the last 15 years. Following the development of bioactive radioiodinated insulin preparations many experiments were performed assessing the binding kinetics of 1251-insulin on intact cells or purified plasma membranes from several tissues. The receptor binding of insulin is characterized by high affinity (KD 1.0 nM) and marked specificity because only insulin and its analogues inhibit binding of 1251-insulin. The initially simple model of a reversible, bimolecular and nonco-operative interaction between receptor and insulin (Gammeltoft & Gliemann, 1973) has been revised to include the existence ofmultiple affinity states (de Meyts et al., 1976; Gammeltoft et al., 1978) . Thus, the insulin receptor exhibits negative co-operativity, as shown in experiments where binding affinity decreased with increasing receptor occupancy (de Meyts et al., 1976) . In addition, formation of a high-affinity state or positive co-operativity was observed at low receptor occupancies (Gammeltoft et al., 1978; Donner & Corin, 1980; Marsh et al., 1984) . The molecular basis of these affinity changes is unknown, but the fact that they are also present in solubilized receptor preparations (Harrison et al., 1978) may suggest that they result from conformational changes within a bivalent insulin receptor structure (Pang & Schafer, 1984; Czech, 1984) .
The interaction of insulin with its receptor induces a variety of biological responses on membrane transport, cell metabolism and growth promotion. However, receptor binding of insulin is irreversible because of degradation of receptor-bound insulin following endocytosis ('internalization') ofthe insulin-receptor complex
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Abbreviations used: EGF, epidermal growth factor; IGF, insulin-like growth factor; PGDF, platelet-derived growth factor; TGF, transforming growth factor. ( Fig. 1) . The dual role of insulin receptors in metabolic regulation and hormone degradation is based on two kinds of experimental evidence: (1) that receptor occupancy elicits biological effects (Gliemann et al., 1975) and leads to insulin degradation (Terris & Steiner, 1975) and (2) that modifications of receptors by trypsin or antibodies to insulin receptors are followed by reduced insulin action (Kono & Barham, 1971; Kahn et al., 1977) and impaired proteolysis of insulin (Terris & Steiner, 1975) . Morphological and biochemical studies have provided evidence that receptor-bound insulin is translocated from the surface to the interior of the cell (for reviews see Gorden et al., 1980; Bergeron et al., 1985) . Endocytosis of 1251-insulin into small cytoplasmic vesicles has been shown by electron-microscopic autoradiography (Carpentier et al., 1979) and subcellular fractionation (Suzuki & Kono, 1979) . It seems likely that insulin is degraded after internalization of the insulin-receptor complex, whereas the receptor is recycled back to the plasma membrane (Fehlmann et al., 1982) . In conclusion, the insulin receptor mediates cellular insulin actions as well as proteolytic degradation of insulin, processes which involve signal transmission from receptor to membrane carriers and intracellular enzymes, regulation of receptor affinity, and internalization of receptor and hormone. The molecular mechanism is not clear, but recent progress regarding receptor structure and function might improve our understanding of insulin action.
Insulin receptor structure The ivisulin receptor is an integral membrane glycoprotein (Mr -300000) composed of two a-subunits (Mr 130000) and two ,-subunits (Mr -95000) linked by disulphide bonds (Fig. 2) . The model is based on application of biosynthetic, cell-surface or affinity labelling of the receptor (Yip et al., 1978; Jacobs et al., 1979; Van Obberghen et al., 1981; Pilch & Czech, 1979; Siegel et al., 1981) . With affinity labelling the a-subunit is labelled predominantly by radioactive insulin when compared with the fl-subunit, the labelling of which is much weaker (Massague et al., 1981) , or even absent (Jacobs et al., 1979) . This suggests that the insulin binding site is located on the a-subunit of the receptor oligomer.
Recent studies (see below) have shown that the fl-subunit is an insulin-sensitive protein kinase which phosphorylates tyrosine residues on the ,-subunit ('autophosphorylation') as well as other substrates. Thus, the insulin receptor is composed of subunits which separately display regulatory and catalytic activity. Several authors have attempted to purify the insulin receptor for further structural analysis. The protocols used were mainly based on affinity chromatography using agarose conjugated with lectins such as concanavalin or wheat-germ agglutinin, followed by insulin-agarose (Cuatrecasas, 1972; Jacobs et al., 1977; Siegel et al., 1981) . Three laboratories succeeded in purifying the receptor from placental membranes (Fujita-Yamaguchi et al., 1983; Roth et al., 1983b; Petruzzelli et al., 1984) . The pure insulin receptor has a binding capacity of 1.1-1.5 mol of insulin/mol of receptor (Mr 300000), and protein kinase activity with Vmax of 80 mmol/min per mg (using angiotensin as substrate; Petruzzelli et al., 1984) .
Recently, the amino-acid sequence of the human insulin receptor precursor was deduced from human placental cDNA clones (Ullrich et al., 1985; Ebina et al., 1985) . This achievement was based on N-terminal sequences obtained for both a-and f-subunits of the purified receptor, which were used for design of single long synthetic DNA probes and hybridization screening S-S4 of a DNA library to identify human insulin receptor cDNA clones. Nucleotide sequence analysis of cDNA positive clones which hybridized with both a-and f-subunit DNA probes revealed a 5181 base-pair-long sequence which coded for 1382 amino acids, including a 27-residue signal peptide. This is the amino-acid sequence of the insulin receptor single chain precursor, composed of an N-terminal a-subunit (735 residues) followed by a f-subunit (620 residues) and an intervening peptide composed of four basic amino acids (Arg-Lys-Arg-Arg), which probably represents the cleavage site for the receptor precursor processing enzyme (Ullrich et al., 1985; Ebina et al., 1985) . The a-chain is largely hydrophilic with a few short hydrophobic stretches, and is probably extracellular. It contains sequences for asparagine N-linked glycosylation and the unusually large number of 37 cysteine residues. The f-chain contains a sequence of 23-26 hydrophobic amino acids, probably representing a single transmembrane region dividing the f-subunit in a shorter extracellular portion, which links the a-subunit through disulphide bridges, and a longer cytoplasmic part (see Fig. 2 ). The a-subunit shows some similarities with the extracellular part of the EGF receptor, in particular in the domain rich in cysteine which may form disulphide bonds resulting in a compact structure . It seems probable that these cysteine-rich clusters may contain the ligand-binding region, as in the low-density lipoprotein receptor (Yamamoto et al., 1984) .
The cytoplasmic part of the insulin receptor ,-subunit shows some homology with other tyrosine-specific kinases like the src oncogene kinases (Heldin & Westermark, 1984; Hunter, 1984) , and the EGF-receptor kinase Ullrich et al., 1984) . The similarities in sequence include the ATP-binding site and the residues essential for kinase activity, as well as tyrosine residues which can be phosphorylated, demonstrating that the insulin receptor is a member of the src family of tyrosine kinases. No cellular proto-oncogene has yet been identified which is identical with the insulin receptor fl-subunit as is the case for the EGF receptor and v-erb B oncogene product Ullrich et al., 1984) , although one region of the insulin receptor fl-subunit (51 residues) is practically identical with a portion of the v-ros protein (Nickameyer & Wang, 1985) . It is possible that the insulin receptor is the cellular homologue of the v-ros transforming protein, which has Mr -68 000, tyrosine kinase activity and a hydrophobic transmembrane region at the N-terminus.
In conclusion, the amino-acid sequence of the insulin receptor substantiates the model that the insulin-binding site is located on the a-subunit, and that the fl-subunit is a tyrosine kinase. Future studies will define the residues interacting with insulin and the phosphorylation sites at tyrosine as well as serine residues which might help in understanding the transmembrane signalling of the insulin receptor. The insulin receptor kinase
In intact cells, insulin stimulates the phosphorylation of its receptor ,8-subunit. This was first demonstrated in rat hepatoma cells and human IM9 lymphoblasts (Kasuga et al., 1982a) and later in freshly isolated rat hepatocytes (Van Obberghen & Kowalski, 1982) . In these experiments, cells were preincubated with [32P]Pi to label cellular ATP, solubilized in detergent, and the glycoproteins purified on wheat-germ-agglutinin-agarose. Immunoprecipitation of phosphorylated proteins by antibodies to insulin receptors followed by SDS/ polyacrylamide-gel electrophoresis under reducing conditions and autoradiography revealed a labelled band (Mr -95000), the phosphorylation of which was stimulated by insulin. Its identity with the insulin receptor f-subunit was established for the following reasons. First, non-immune serum did not precipitate a band with a similar electrophoretic mobility. Second, the molecular size was identical with that previously determined using biosynthetic, cell surface, and affinity labelling methods (Jacobs et al., 1979; Van Obberghen et al., 1981; Massague et al., 1981) . Subsequently, insulin-stimulated phosphorylation of the f-subunit of insulin receptor was demonstrated in cell-free systems using [y-32P]ATP in solubilized and partially purified receptor preparations from rat liver ( Fig. 3 ) and human placenta, and analysis of phosphoaminoacids showed predominant labelling of phosphotyrosine and to a smaller degree of phosphoserine (Kasuga et al., 1982b,; Van Obberghen et al., 1983 : Avruch et al., 1982 Petruzzelli et al., 1982; Roth & Cassell, 1983; . In intact cells phosphoaminoacid analysis of the phosphorylated fisubunit of insulin receptors showed phosphoserine, phosphothreonine and phosphotyrosine under basal conditions. Insulin induced a rapid, several-fold increase in 32p incorporation in tyrosine, followed by a slower rise Vol. 235
in labelling of phosphoserine (Kasuga et al., 1982c; Gazzano et al., 1983; Zick et al., 1983a; Pang et al., 1985; White et al., 1985) . The insulin receptor exhibits insulin-dependent tyrosine-kinase activity. This was demonstrated in cell-free systems with detergent-solubilized and highly purified receptors obtained from various tissues. The purification scheme was based on sequential affinity chromatography on wheat germ agglutinin-and insulin-agarose (FujitaYamaguchi et al., 1983; Roth et al., 1983b; Petruzzelli et al., 1984; Nemenoffet al., 1984; Kasuga et al., 1983a,b) . Alternatively, the lectin-purified receptors were immunoprecipitated with antibodies to insulin receptors obtained from patients with severe insulin-resistance and acanthosis nigricans (Kasuga et al., 1982b; Van Obberghen et al., 1983) , or monoclonal IgG directed against insulin receptors (Roth et al., 1982; Kull et al., 1983) . These purified receptor preparations exhibited insulinstimulated protein kinase activity which catalysed phosphorylation of both the f-subunit and exogenous substrates like casein, histones and synthetic tyrosinecontaining peptides. In contrast with the partially purified receptor, the phosphorylation occurred exclusively on tyrosine residues in highly purified receptors under basal conditions, and the insulin stimulatory action was accounted for by a several-fold increase in phosphotyrosine (Avruch et al., 1982; Petruzzelli et al., 1982 Petruzzelli et al., , 1984 Gazzano et al., 1983; Kasuga et al., 1983a; Roth & Cassell, 1983; . Thus, the tyrosine kinase is a constituent of the insulin receptor, whereas the serine kinase is non-covalently associated with the receptor (Fig. 2) . The simultaneous presence of a phosphorylation site and an ATP-binding site on the f-subunit suggests that the insulin receptor acts as its own tyrosine kinase. Further proofofthe identity ofthe insulin receptor kinase seems to be the demonstration that the insulin-binding activity and the insulin-dependent tyrosine-kinase activity co-purified at a constant stoichiometric ratio to homogeneity (Roth & Cassell, 1983; Kasuga et al., 1983a, b; Nemenoff et al., 1984; Petruzzelli et al., 1984 (White et al., 1984) . Even at 4°C, the phosphorylation was rapid; the 32P content of the receptor reached half-maximal level by 5 min and maximum after about 20 min (Zick et al., 1983c) . As with the EGF-stimulated phosphorylation of the EGF receptor (Carpenter et al., 1979; Pike et al., 1984) , Mn2+ was the most potent cation in augmenting the insulin-stimulated phosphorylation ofthe insulin receptor (Avruch et al., 1982; Petruzzelli et al., 1984; White et al., 1984; Zick et al., 1983c; Pike et al., 1984) . The effect of Mn2+ was maximal at concentrations above 2 mm and constant up to 10 mM (Pike et al., 1984) , but showed a complex relationship with the ATP concentration (see below). Mg2+ was also effective, but concentrations above 15 mM were required for a maximal effect. However, the insulin-stimulated kinase showed greater activity in the presence of a combination of 2 mM-Mn2+ and 12 mM-Mg2+ than when either metal ion was used alone (Pike et al., 1984) . Ca2+ as well as Zn2+ and Cr2+ were totally ineffective, whereas Co2+ (2 mM) had some effect (Avruch et al., 1982; Zick et al., 1983c) . This ion dependency is characteristic of tyrosine kinases compared with serine kinases and threonine kinases (Cohen, 1982) .
In the cell-free system, the source of phosphate used to phosphorylate the f-subunit was identified as ATP (Kasuga et al., 1982b) , and the Km value for ATP of the insulin-stimulated receptor kinase was determined as 30-150 /zM (Petruzzelli et al., 1984; Nemenoffet al., 1984; White et al., 1984; Pike et al., 1984) . No other nucleoside triphosphate (GTP, CTP, dTTP or UTP) competed with [y-32P]ATP in the receptor phosphorylation assay, whereas addition of ATP and ADP, but not AMP, gave significant inhibition of 32P incorporation White et al., 1984; Pike et al., 1984) . Cyclic AMP had no effect on the phosphorylation of the receptor (Petruzzelli et al., 1982; Nemenoff et al., 1984; Zick et al., 1983c) . Thus, the insulin receptor kinase showed specificity for adenosine di-and tri-phosphates. As mentioned above, Mn2+ and ATP showed a complex relationship in their activation of the kinase. Kinetic data showed that Mn2+ acted predominantly by decreasing the Km, for ATP, presumably through binding to a specific regulatory site on the kinase rather than chelating with ATP. On the other hand, increasing ATP concentration decreased the Km, for Mn2 , showing that a high substrate concentration can activate the kinase even when the metal activator concentration is low (White et al., 1984) .
The substrate specificity of the insulin receptor kinase was assessed using both naturally occurring proteins and synthetic peptides including histones, casein, tubulin, troponin, angiotensin II, angiotensin III inhibitor, fi-lipotropin, pp60src (a gene product of the Rous sarcoma virus), anti-pp6osrc IgG, and several synthetic peptide fragments containing a tyrosine residue Nemenoff et al., 1984; Kasuga et al., 1983b; Pike et al., 1984; Stadtmauer & Rosen, 1983) . In the proteins, phosphoaminoacid analysis showed only phosphorylation on tyrosine residues. Among the synthetic peptides, even the dipeptide Tyr-Arg was a substrate, although with very high Km (Stadtmauer & Rosen, 1983 Kasuga et al. (1982a-c) , Van Obberghen et al. (1983 , Haring et al. (1982 Haring et al. ( , 1984b , Velicelebi & Aiyer (1984) , Burant et al. (1984 ), Petruzzelli et al. (1982 , Roth & Cassell (1983) , (1982b, 1983a,b) , Van Obberghen et al. (1983) , Roth et al. (1982 , Petruzzelli et al. (1984 Gazzano et al. (1983 , Kasuga et al. (1983b) , Pike et al. (1984) , Stadtmauer & Rosen (1983) , Sadoul et al. (1985) , 
the insulin receptor kinase was similar to, but not identical with, that of the EGF receptor (Carpenter et al., 1979; Pike et al., 1984; Blackshear et al., 1984) and the pp60src kinases (Hunter, 1982) , suggesting that they are members of a superfamily of tyrosine kinases which have diverged from a common evolutionary origin. It seems that the insulin receptor f-subunit is the best substrate for its own kinase. This conclusion is based on the observation that the Vmax for autophosphorylation of the insulin receptor kinase was increased nearly 20-fold by insulin (White et al., 1984) , whereas the Vmax values for other substrates were only increased 2-5-fold Kasuga et al., 1983b; Pike et al., 1984; Stadtmauer & Rosen, 1983) . Alternatively, it has been suggested that the kinase activity associated with the insulin receptor is increased by tyrosine phosphorylatiorn, ofthe receptor f-subunit Yu & Czech, 1984; Yu et al., 1985) . Phosphorylation on tyrosine residues induced by insulin leads to increased kinase activity, whereas dephosphorylation of the tyrosine residues by alkaline phosphatase is accompanied by a marked inhibition (Yu & Czech, 1984) . Thus, the autophosphorylation on tyrosine residues may play a key role in regulating the insulin receptor kinase. The additional phosphorylation of serine and threonine residues on the receptor by non-covalently associated kinases may also exert a regulatory role on insulin receptor kinase and binding activity (Czech, 1984) .
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Role of receptor phosphorylation in insulin action
The biological relevance ofinsulin receptor phosphorylation is not clear. It is possible that it plays a role in cellular processes such as receptor affinity regulation, hormone and receptor internalization and signal transmission. These phenomena are well-characterized (for reviews see Kahn et al., 1981; Gammeltoft, 1984) , but their molecular mechanism is almost completely unknown. Most likely receptor regulation, internalization and transmembrane signalling are integrated events in insulin action, and receptor autophosphorylation per se is involved in transmission of the insulin message to cellular enzymes and transport carriers. At present, it is tempting to suggest that the covalent receptor modification is an early step in insulin action and that the increased kinase activity of the insulin receptor evoked by hormone binding would lead to phosphorylation-dephosphorylation of other cellular proteins, and through the generation of a cascade of reactions this would result in the final effects of insulin. Five requirements should be fulfilled by the insulininduced receptor kinase activation and autophosphorylation in order to be involved in insulin action.
First, the insulin dose-response relationship of the kinase should be within the physiological range and correlate with that of the binding to the receptor. Several authors found that the kinase activation was half-maximal at an insulin concentration of 2-5 nM (-ED50; effective dose for 50% activation), which corresponded to the apparent Kd ofthe receptor-insulincomplex as determined with the same preparations of solubilized receptor of varying purity obtained from human placenta (Kasuga et al., 1982c; Avruch et al., 1982; Petruzzelli et al., 1984; Nemenoffet al., 1984; Pike et al., 1984; Rosen et al., 1983; Sadoul et al., 1985) . In contrast, a dissociation between the dose-response curves of insulin binding and kinase activation was observed with soluble receptors from rat liver and human erythrocytes (Zick et al., 1983c; Grigorescu et al., 1983) . In these studies, the apparent Kd exceeded the ED50 by a factor of 3-10, suggesting that the phenomenon of ' spare receptors' observed for other insulin actions (for review see Gammeltoft, 1984) is also applicable for kinase activation. It is not clear whether the different findings are explained by differences in the tissues, purification procedures, or assay methods used. In conclusion, the receptor kinase is activated by insulin concentrations within a physiological range corresponding to receptor binding.
Secondly, the receptor kinase should be capable of phosphorylating other cellular substrates than the receptor itself, in order to propagate the insulin response. As discussed in detail above, the insulin receptor kinase is capable of phosphorylating a number of substrates on tyrosine residues in vitro, although none of the proteins tested are physiological substrates Petruzzelli et al., 1984; Kasuga et al., 1983b; Pike et al., 1984; Stadtmauer & Rosen, 1983) . Recently, two laboratories, independently, identified a cellular protein substrate of Mr -110000-120000 for the insulin receptor kinase in wheat-germ-agglutinin purified glycoproteins from rat liver and rabbit brown adipose tissue (Sadoul et al., 1985; Rees-Jones & Taylor, 1985) .
The naturally occurring glycoprotein appears as a monomeric structure, and is not part of the insulin receptor itself, because it was not immunoprecipitated by highly specific antibodies to insulin receptor. Phosphorylation of the Mr 110000 protein and autophosphorylation of the receptor f-subunit (Mr -95 000) were stimulated by insulin in a remarkably similar dosedependent fashion with ED50 of 1 nm. Further kinetic studies suggested that the phosphorylation of the Mr 1 0000 protein occurred after autophosphorylation of the insulin receptor kinase (Sadoul et al., 1985) . The nature and function of this endogenous substrate is yet unknown, as well as the intriguing question whether it displays kinase or phosphatase activity.
In intact cells, the rapid insulin-stimulated phosphorylation of its receptor on tyrosine residues is followed by a slower serine phosphorylation (Kasuga et al., 1982c; Pang et al., 1985; White et al., 1985) . Furthermore, in a cellfree system of partially purified insulin receptor, some laboratories have reported that insulin stimulates phosphorylation of both tyrosine and serine residues on its receptor (Kasuga et al., 1982c; Zick et al., 1983a; Yu & Czech, 1984) as well as on exogenous substrates . The serine kinase is non-covalently associated with the receptor, and is removed during further purification, because the highly purified receptor displayed only tyrosine kinase activity (Kasuga et al., 1982c Gazzano et al., 1983; Petruzzelli et al., 1984; Nemenoff et al., 1984) . The relationship between the two protein kinase activities associated with the (Fig. 4) , one in which both kinases serve separate cellular functions, and another one with sequential activation of the kinases . The first model implies that the tyrosine-specific enzyme activity is involved in insulin's growth-promoting action similar to the tyrosine phosphorylations mediating the cellular responses to growth factors such as EGF (Cohen et al., 1980) , PDGF (Ek et al., 1982) and TGF-a (Reynolds et al., 1981) and several cellular and retroviral oncogene proteins (Hunter, 1982 (Hunter, , 1984 Bishop, 1983; Heldin & Westermark, 1984) . In contrast, the serine kinase would play a role in insulin's metabolic actions. All kinases involved in the control of intermediary metabolism are indeed serine-or threonine-specific (Denton et al., 1981; Cohen, 1982) , and phosphoserine and phosphothreonine constitute about 99.97% of all phosphorylated amino acids, phosphotyrosine accounting for the remaining 0.03% (Hunter & Sefton, 1980) . In the second model, the two kinases are activated sequentially. Insulin binding to its receptor leads to activation of the constituent tyrosine kinase, which then induces activation of the receptor-associated serine kinase and this last one accounts for the generation of cellular responses to insulin. Future work should be directed towards the identification of the serine kinase.
The third criterion is that of reversibility of insulin receptor phosphorylation. To exert a regulatory function, the phosphorylated and activated receptor kinase should return to basal activity through a dephosphorylation reaction. Solubilized, lectin-purified receptors from rat liver membranes contained phosphatase activity, which slowly reduced the 32P content of the phosphorylated receptor, and which was insulin-independent (Haring et al., 1984a; Kowalski etal., 1983; Zick etal., 1983b) . The significance of this reaction is difficult to ascertain, in particular because a 2 h incubation at 22°C was required forcomplete dephosphorylation ofthe receptor . A different approach was taken by incubation of the phosphorylated insulin receptor with alkaline phosphatase, which resulted in removal of about 50% of the phosphotyrosine in the ,-subunit, and about 65% reduction in kinase activity, suggesting that dephosphorylation is accompanied by deactivation of the receptor kinase (Zick et al., 1983b; Yu & Czech, 1984 ). These observations demonstrate that the insulin receptor 1986 kinase can be deactivated through dephosphorylation of phosphotyrosine residues.
The fourth criterion regards the specificity of the insulin effect on its receptor kinase. Several insulin analogues, including porcine proinsulin, des-octapeptideinsulin, des-alanine-des-asparagine-insulin, guinea pig insulin, insulin-like growth factor II and covalently linked insulin dimers stimulated receptor phosphorylation with potencies relative to porcine insulin which were identical with their relative binding affinities and potencies in other assay systems (Kasuga et al., 1982b; Petruzzelli et al., 1982; Zick et al., 1983c; Pike et al., 1984; Grigorescu et al., 1983; Roth et al., 1984) . Furthermore, polyclonal antisera directed against the insulin receptor, which show insulin-like effects in several cell types, were also able to stimulate the tyrosine-specific kinase associated with the receptor (Petruzzelli et al., 1982; Zick et al., 1984) .
However, some antibodies were inactive, although they showed both insulin-like effects in intact cells and interaction with receptors in cell-free preparations (Zick et al., 1984; Simpson & Hedo, 1984) . The reason for this discrepancy is not clear, but a possible explanation is that activation of the receptor-associated tyrosine kinase mediates the growth activity of insulin and not the metabolic actions (cf. Fig. 4 ). Finally, other hormones which do not bind to the insulin receptor, including EGF, which activates its own receptor kinase, had no effect on insulin receptor kinase activity (Pike et al., 1984; Zick et al., 1983b) . In conclusion, the insulin effect on phosphorylation of its own receptor has the affinity and specificity of a typical insulin receptor mediated event.
Finally, the kinase activity of the insulin receptor seems to be a fundamental property, since whenever insulin receptors are present, insulin-stimulated autophosphorylation ofits receptorf,-subunit can be demonstrated. This applies to all tissues investigated so far, including liver (Kasuga et al., 1982b; Van Obberghen et al., 1983) , adipose tissue (Haring et al., 1982; Velicelebi & Aiyer, 1984) , muscle (Burant et al., 1984; Haring et al., 1984b; Le Marchand-Brustel et al., 1985) , placenta (Petruzzelli et al., 1982; Roth & Cassell, 1983; , lymphocytes (Grunberger et al., 1984a) , erythrocytes (Grigorescu et al., 1983) , fibroblasts , brain cortex (Gammeltoft et al., 1984a; Rees-Jones et al., 1984) , and various cell lines like IM 9 lymphoblasts (Kasuga et al., 1982a) , 3T3-L1 adipocytes (Petruzzelli et al., 1982) , hepatoma cells (Kasuga et al., 1982a, c; White et al., 1984) and insulinoma cells . Thus, the insulin-sensitive kinase is a general feature of the insulin receptor.
Additional evidence for a role ofinsulin receptor kinase in insulin action was obtained by two kinds of observations (Table 2) . First, the receptor kinase activity is impaired in cells from various insulin-resistant states including the syndrome of insulin resistance and acanthosis nigricans, type A (Grunberger et al., 1984a, b; Grigorescu et al., 1984) , melanoma cell cultures (Haring et al., 1984c) , gold thioglucose obese mice (Le MarchandBrustel et al. 1985) , and streptozotocin diabetic rats . Second, insulinomimetic agents like vanadate, concanavalin A, wheat germ agglutinin, and trypsin, which act via the insulin receptor, increased the receptor autophosphorylation Tamura et al., 1983a, b; Roth et al., 1983a) .
In conclusion, five criteria are fulfilled which establish the kinase as fundamental property of the insulin receptor and strongly suggest its important role in insulin action. Data from several laboratories suggest that receptor phosphorylations are involved in insulin receptor autoregulation and in the transmission of the insulin signal. At present there is no information on a role in insulin receptor internalization. It has been proposed that tyrosine phosphorylation of the f-subunit regulates its kinase activity, whereas receptor phosphorylation on serine and threonine residues could play a role in modulation of affinity of the a-subunit. Furthermore, phosphorylation of an endogenous substrate on tyrosine and serine might represent the secondary event leading to insulin actions on metabolism and growth.
Heterogeneity of insulin receptors
Insulin elicits a diversity of biological responses in a large number of vertebrate tissues. The regulatory effects include activation of transport processes for glucose, amino acids and ions, regulation of enzyme activities involved in carbohydrate, lipid and protein metabolism and modulation of cell growth. These insulin actions show a variation in their time of onset and their dose-response relationship ranging from acute effects (seconds to minutes) on transport and enzyme systems at low insulin concentrations to slow promotion (hours) of cell proliferation at higher insulin levels Denton et al., 1981; Czech, 1984) . The various effects of insulin on different cell types are mediated by membrane receptors which are homologous in their structural and functional characteristics. However, Table 2 . Evidence for a role of insulin receptor kinase in insulin action Feature experimental evidence has accumulated that insulin receptors also show striking tissue and species differences in their subunit size, binding kinetics, and peptide specificity, whereas their tyrosine kinase activity is more conserved. This heterogeneity may be linked to the different physiological actions of insulin in various tissues, and three examples will be discussed.
Two of the major insulin targets, liver and fat, show significant differences in receptor binding kinetics. The association rate and binding affinity of receptor-insulin interaction is higher in liver than in fat cells (Kd 0.5 nM versus 3.0 nM) (Gammeltoft & Gliemann, 1973; Gammeltoft et al., 1978) . Furthermore, the coupling between receptors and metabolic effects of insulin is different. Binding and action are almost linearly coupled in liver, whereas fat cells display the 'spare receptor' phenomenon (Gliemann et .al., 1975) . It seems likely that receptors in liver and fat adapt to different ambient insulin concentrations in the portal and extraportal circulation.
In liver the values of K,, for receptor binding of insulin and ED50 for insulin-stimulated glycogenesis are within the physiological range of concentrations of portal insulin. In fat cells the ED50 for insulin-stimulated glucose transport is similar to insulin levels in peripheral venous plasma, but the value of Kd for receptor binding is about 50 times higher. Thus, under physiological conditions, maximal effects are obtained by receptor occupancies of -90% in liver versus -5-10% in fat cells (Gammeltoft, 1984) . Structural differences may also exist because antigenic determinants and glycosylation of insulin receptors in liver and fat cells seem to vary whereas the molecular size and subunit composition are similar (Kahn et al., 1977; Pottick et al., 1981) . Insulin receptors are widespread in mammalian brain (Havrankova et al., 1978; Hendricks et al., 1983 ) and recent observations suggest that they may represent a structural and functional receptor subtype among insulin receptors (for review see Gammeltoft et al., 1985a) . The electrophoretic mobility of brain receptor a-subunits is significantly smaller than in other tissues (Mr 115000 versus 130000) (Fig. Sa) whereas that of the fl-subunit (Mr -94000) is similar (Fig. Sb) (Yip et al., 1980; Heidenreich et al., 1983; Gammeltoft et al., 1984a; Rees-Jones et al., 1984) . The binding properties show striking differences in comparison with other cell types, because negatively co-operative interactions are absent (Gammeltoft et al., 1984b; Van Schravendijk et al., 1984) and the insulin specificity is different (Gammeltoft et al., 1984b (Gammeltoft et al., , 1985b . Thus, insulin from a hystricomorph rodent, the coypu, and insulin-like growth factors (IGF I and II) are bound with higher affinity in brain than in liver and fat cells. This observation may suggest that brain insulin receptors mediate the growth activity of insulin because hystricomorph insulins and IGFs are more potent growth promotors than other insulin analogues . Indeed, studies in fetal rat brain suggest that insulin may act as a growth factor in nervous tissues rather than as a metabolic regulator, as discussed elsewhere (Gammeltoft et al., 1985a) . It should be emphasized that insulin and IGFs interact with separate receptors in the central nervous system (Gammeltoft et al., 1985b) .
Finally, insulin receptors in human IM-9 lymphoblasts show different characteristics in comparison to those in liver and fat cells regarding faster association and dissociation kinetics of receptor-bound insulin, complete absence of receptor-mediated insulin degradation and a greater Mr of a-and fl-subunits (Sonne & Gliemann, 1980; Van Obberghen et al., 1981) . The observed differences may indicate that the insulin receptors of transformed cell lines in culture generally have greatly altered properties which may be linked to a different role of insulin in these cells. It should be added that the rate of receptor-mediated insulin degradation shows species variations because it is much faster in rat tissues than in human fat cells and monocytes (Beck-Nielsen & Pedersen, 1979; Pedersen et al., 1981) . The significance of these variations is not clear at present.
In conclusion, insulin receptors show a structural and functional heterogeneity probably related to the diversity of insulin action. A resolution of the receptor amino acid sequence in tissues other than human placenta (Ullrich et al., 1985; Ebina et al., 1985) might help in understanding the structure-function relationship of the insulin receptor.
Summary and conclusions
The insulin receptor is an integral membrane glycoprotein (Mr 300000) composed of two a-subunits (Mr -130000) and two ,-subunits (Mr 95000) linked by disulphide bonds. This oligomeric structure divides the receptor into two functional domains such that a-subunits bind insulin and f-subunits possess tyrosine kinase activity. The amino acid sequence deduced from cDNA of the single polypeptide chain precursor of human placental insulin receptor revealed that a-and f-subunits consist of 735 and 620 residues, respectively. The a-subunit is hydrophilic, disulphide-bonded, glycosylated and probably extracellular. The f-subunit consists of a short extracellular region which links the a-subunit through disulphide bridges, a hydrophobic transmembrane region and a longer cytoplasmic region which is structurally homologous with other tyrosine kinases like the src oncogene product and EGF receptor kinases.
The cellular function of insulin receptors is dual: transmembrane signalling and endocytosis of hormone. The binding of insulin to its receptor on the cell membrane induces transfer of signal from extracellular to cytoplasmic receptor domains leading to activation ofcell me,tabolism and growth. In addition, hormone-receptor complexes are internalized leading to intracellular proteolysis of insulin, whereas receptors are recycled to the membrane. These phenomena are kinetically wellcharacterized, but their molecular mechanisms remain obscure.
Insulin receptor in different tissues and animal species are homologous in their structure and function, but show also significant differences regarding size of a-subunits, binding kinetics, insulin specificity and receptor-mediated degradation. We suggest that this heterogeneity of receptors may be linked to the diversity in insulin effects on metabolism and growth in various cell types.
The purified insulin receptor phosphorylates its own fl-subunit and exogenous protein and peptide substrates on tyrosine residues, a reaction which is insulin-sensitive, Mn2+-dependent and specific for ATP. Tyrosine phosphorylation of the f-subunit activates receptor kinase activity, and dephosphorylation with alkaline phos- The mobility of brain insulin receptor f-subunits (Mr -94000) is identical with that of liver receptor f-subunits (cf. Fig. 3 ) (data from Gammeltoft et al., 1984a Gammeltoft et al., , 1985a .
receptor preparations, a serine kinase is also activated by insulin. The cellular role of two kinase activities associated with the insulin receptor is not known, but we propose that the tyrosine-and serine-specific kinases mediate insulin actions on metabolism and growth either through dual-signalling or sequential pathways. A cellular glycoprotein (Mr 110000), the phosphorylation of which is stimulated by insulin, may represent a physiological substrate of the receptor-associated kinases and an intermediary step in insulin action. Several arguments are in favor of this model: the identical insulin dose-response relationships of receptor binding, kinase activation and substrate phosphorylation; the insulin specificity of receptor kinase activation; the invariable association between binding and kinase activities of insulin receptors; and the impairment of receptor kinase activity in various insulin-resistant states.
